MBX BIOSCIENCES - PENDING ALIGNMENT WITH FDA, PHASE 2 STUDY OF MBX 1416 IN PATIENTS WITH PBH ANTICIPATED IN SECOND HALF OF 2025

Reuters · 01/07 12:00

Please log in to view news